- Risk Score Based on Two microRNAs as a Prognostic Marker of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network
Xiao-Chun Huang et al, 2021, International Journal of General Medicine CrossRef - The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
Xinyao Hu et al, 2021, Frontiers in Oncology CrossRef - Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition
Shengwei Tao et al, 2023, Frontiers in Immunology CrossRef - The current status and future of PD-L1 in liver cancer
Liyuan Hao et al, 2023, Frontiers in Immunology CrossRef - The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
Chen Xue et al, 2022, Frontiers in Immunology CrossRef - Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties
Tong Hu et al, 2024, WIREs RNA CrossRef - Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs)
Masoumeh Eliyasi Dashtaki et al, 2023, Current Molecular Pharmacology CrossRef - Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis
Kadeerjiang Musha et al, 2022, Disease Markers CrossRef - Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian et al, 2022, Frontiers in Pharmacology CrossRef - CircFMN2 Boosts Sorafenib Resistance in Hepatocellular Carcinoma Cells via Upregulating CNBP by Restraining Ubiquitination
Chen Fan et al, 2022, Journal of Oncology CrossRef - Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef - Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou et al, 2022, Frontiers in Oncology CrossRef